Asthma :: Bronchial thermoplasty reduces asthma attacks
The removal of muscle tissue in the hyperactive airways of asthma patients by exposing the tissue to heat reduces disease exacerbations and significantly improves the patients’ quality of life.
College
Mumps :: Mumps activity in US highlights vaccine importance
In the wake of growing number of mumps cases in the US, the American medical authorities have updated their vaccination recommendations & asked for utilizing every opportunity to provide immunization to high-risk populations.
Health :: No link between juice and children’s weight
Drinking a glass of 100 percent fruit juice has long been thought of as a healthy habit for both adults and children. Recently, however, people have been confused about juice — how much to drink, how much to serve their children — partly because of the natural sweet taste of fruit juice.
Tuberculosis :: Drug Resistant Tuberculosis an emerging threat
Strains of tuberculosis (TB) that are resistant to both first-line and second-line drugs could threaten the success of not only tuberculosis programs, but also HIV treatment programs worldwide, according to an article published online this week in The Lancet. The report details a study by a team of investigators from the United States and South Africa, who found that highly resistant strains of TB were more common than previously thought in a rural area of KwaZulu Natal, South Africa, and were associated with high death rates in patients with HIV infection. TB accounts for approximately 1.7 million deaths worldwide, each year, and is the leading cause of death in HIV-infected patients in low-income countries.
Exercise :: Walking not enough for significant exercise benefits
Walking is a popular form of exercise, but may not be enough to experience significant health benefits, a University of Alberta study shows. “Generally, low-intensity activity such as walking alone is not likely going to give anybody marked health benefits compared to programs that occasionally elevate the intensity,” said Dr. Vicki Harber, lead author on the Health First study, which was presented recently at the American College of Sports Medicine annual conference.
Gene :: Scientists Publish Analysis of Honey Bee Genome
A research consortium, supported by the National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), today announced the publication of a high-quality draft genome sequence of the western honey bee, finding that its genome is more similar to humans than any insect sequenced thus far.
Ulcerative Colitis :: Mesalamine associated with rapid mucosal healing in ulcerative colitis patients
Combined data analysis from two trials demonstrated that treatment success is associated with mucosal healing in patients with moderately active ulcerative colitis who received either 2.4 or 4.8 grams of mesalamine per day. By 6 weeks, 67% of patients achieved both treatment success and mucosal healing, while only 5% achieved treatment success without demonstrating mucosal healing. The results were presented by University of Chicago researcher David T. Rubin, MD, at the annual scientific meeting of the American College of Gastroenterology (ACG).
Ulcerative Colitis :: Adherence to ulcerative colitis medications is not affected by drug formulation or dosing regimen
Poor adherence to medication is a recognized medical problem, costing an estimated $100 billion a year in the United States.(i) New data show that while there is a steady decline in adherence to medications for ulcerative colitis (UC), drug formulation and the number of pills taken each day do not affect long-term adherence. The data were presented today at the annual scientific meeting of the American College of Gastroenterology by University of Chicago researcher Sunanda Kane, M.D.
Dyspepsia :: Zelnorm, tegaserod maleate for relief of multiple symptoms of dyspepsia – Novartis
The gastrointestinal medicine Zelnorm? (tegaserod maleate) has demonstrated potential benefits in helping patients with the multiple symptoms of a common digestive disorder called dysmotility-type dyspepsia[1], according to new Phase III data presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting.
Crohn’s Disease :: Promising results in tough-to-treat crohn’s disease patients
Abbott announced results from a study showing HUMIRA? (adalimumab) induced significantly higher rates of clinical remission compared to placebo in patients with moderately to severely active Crohn’s disease who lost response to, or were intolerant to, infliximab therapy. The data is being presented simultaneously at the American College of Gastroenterology (ACG) annual meeting in Las Vegas and the United European Gastroenterology Week (UEGW) in Berlin.